Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2016. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138141000087119 | MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 71381000087110 | Men-C-C MENJUGATE GSK | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 71401000087110 | MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 75861000087114 | Men-C-C MENJUGATE GSK | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Count of active ingredient | un | false | Inferred relationship | Some | ||
| MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has supplier | GlaxoSmithKline Inc. (supplier) | true | Inferred relationship | Some | ||
| MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Vaccine product containing only Neisseria meningitidis serogroup C conjugated antigen (medicinal product) | true | Inferred relationship | Some | ||
| MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | poudre pour suspension injectable | true | Inferred relationship | Some | ||
| MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Neisseria meningitidis serogroup C capsular oligosaccharide antigen conjugated to Corynebacterium diphtheriae CRM197 protein | true | Inferred relationship | Some | 1 | |
| MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Meningococcal C conjugate vaccine (product) | false | Inferred relationship | Some | ||
| MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Meningococcus vaccine (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR